MedTrace Logo

Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms

NCT03182738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-12-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to use technology to improve symptom status and ultimately improve patient centered outcomes in people living with HIV/AIDS (PLWHA). The primary purpose of the intervention (VIP-HANA) is to improve symptom status. The investigators hypothesize that VIP-HANA will improve symptom frequency and intensity.

Conditions

  • HIV (Human Immunodeficiency Virus)
  • AIDS (Acquired Immunodeficiency Syndrome)

Interventions

BEHAVIORAL

VIP app without HIV-related symptom strategies.

The control group will receive the VIP app without HIV-related symptom strategies

BEHAVIORAL

VIP app that delivers HIV-related symptom strategies.

The Intervention group will receive the VIP app that delivers HIV-related symptom strategies

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Rebecca Schnall, PhD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-16
Primary Completion
2019-04-03
Completion
2019-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182738 on ClinicalTrials.gov